» Articles » PMID: 30372144

Thrombogenic and Arrhythmogenic Roles of the Left Atrial Appendage in Atrial Fibrillation

Overview
Journal Circulation
Date 2018 Oct 30
PMID 30372144
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding the anatomy, physiology, and arrhythmogenic and thrombogenic roles of the left atrial appendage (LAA) has become very important. The potential deleterious effects of this chamber in patients with atrial fibrillation have led to the development of specific treatments for this structure. It has been established that the LAA is the area where the vast majority of thrombi in nonvalvular atrial fibrillation are formed and that some LAA morphologies may actually facilitate thrombi formation and risk stratification for thromboembolic events in patients with low CHADS-VASc scores. Likewise, clinical data supporting the role of LAA electric isolation to improve freedom from all-atrial arrhythmias are rapidly growing. Acute LAA electric isolation can be achieved in most cases of catheter ablation for atrial fibrillation. However, late LAA reconnections are frequent. Special considerations should be taken when this procedure is performed to avoid myocardial perforation, left phrenic nerve, and left circumflex coronary artery damage. LAA electric isolation is a safe procedure that does not increase the risk of stroke as long as patients remain compliant with lifelong anticoagulation regardless of CHADS-VASc score. Finally, ligation of the LAA has recently been associated with modulation of the renin-angiotensin-aldosterone system with clinical implications in blood pressure control.

Citing Articles

Beyond the Beat: A Multifaceted Review of Atrial Fibrillation in Sepsis: Risk Factors, Management Strategies, and Economic Impact.

Ho W, Umais M, Bai M, Dang N, Kumari K, Izhar S Cardiol Res. 2025; 16(1):1-14.

PMID: 39897439 PMC: 11779681. DOI: 10.14740/cr1723.


Multiphysics simulations reveal haemodynamic impacts of patient-derived fibrosis-related changes in left atrial tissue mechanics.

Gonzalo A, Augustin C, Bifulco S, Telle A, Chahine Y, Kassar A J Physiol. 2024; 602(24):6789-6812.

PMID: 39513553 PMC: 11652225. DOI: 10.1113/JP287011.


Pulsed Field Ablation for Atrial Fibrillation: Mechanisms, Advantages, and Limitations.

Jiang S, Qian F, Ji S, Li L, Liu Q, Zhou S Rev Cardiovasc Med. 2024; 25(4):138.

PMID: 39076550 PMC: 11264014. DOI: 10.31083/j.rcm2504138.


Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study.

Okada M, Inoue K, Tanaka N, Tanaka K, Hirao Y, Iwakura K Europace. 2024; 26(5).

PMID: 38691672 PMC: 11106584. DOI: 10.1093/europace/euae120.


Limitations in Contemporary Pharmacological Stroke Prevention Therapies in Atrial Fibrillation: A Descriptive Literature Review.

Garot P, Bergmann M J Clin Med. 2023; 12(20).

PMID: 37892737 PMC: 10607152. DOI: 10.3390/jcm12206594.